Ranbaxy’s Globalization Strategies and its Foray Into the US
Entry and expansion strategies of Ranbaxy in foreign markets
The case discusses the globalization efforts of Ranbaxy Laboratories (Ranbaxy), a leading pharma company in India. Ranbaxy started off distributing drugs in foreign countries and went on to play a major role in the global generics market. By 2004, the company had manufacturing plants in 10 locations, ground operations in 45 countries and its products were sold in 70 countries across the world. The case describes Ranbaxy’s foray in the US markets where it made a slow entry and adopted the route of Para IV filings to challenge the supremacy of big pharma companies. By the first quarter of 2005, Ranbaxy’s sales in the US decreased by US$ 25 million, which was attributed to severe price erosion in these markets due to increasing competition among the US generics. The case describes the challenges facing the company in the US and examines Ranbaxy’s growth strategy for the US markets.
» Entry and expansion strategies of Ranbaxy in foreign markets
» Growth initiatives of Ranbaxy in the US
» Challenges faced by Ranbaxy in the US
Case study help
Essay writing and editing
Thesis writing & editing
09901366442 – 09902787224
We are a team of highly committed professionals, who aim at helping Clients to achieve their Goals. We believe in establishing long-term relationships with our clients by delivering value added services of high quality. We are sensitive to our Clients requirements without compromising on values like Integrity and trust. Understanding the abilities, offering them Quality services and meeting our client’s requirements at the right time are our Forte.
We are in to this business since 14 years. And we are providing case study Answers, Assignment solutions, Multiple Question Answers and Project Reports of more than 40 + International B School (Indian and Foreign Universities)